FindTrial
Sign In

Long term safety of ultra-long 48mm stents

Immediate procedural safety and long-term efficacy of Ultra-long 48 mm Xience-Xpedition stents: A real world experience from India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036701
Enrollment
100
Registered
2021-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z988- Other specified postprocedural states

Interventions

Intervention1: NIL: NIL

Sponsors

Department of Cardiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who underwent percutaneous coronary intervention using Xience Xpedition 48 mm long stent (Abbott vascular  Santa Clara, CA ) who will be willing to give informed consent

Exclusion criteria

Exclusion criteria: Patients who will not give consent Patients who could not be contacted

Design outcomes

Primary

MeasureTime frame
Major adverse cardiac events (MACE) – Death /MI/ reinterventionTimepoint: follow up at least 1 year—

Secondary

MeasureTime frame
Death, MI, repeat revascularization, procedural success, clinical restenosis which is defined as target lesion revascularization or positive stress test in the intervened vessel or more than 50% in stent stenosis in the angiogramTimepoint: Follow up of at least 1 year—

Countries

India

Contacts

Public ContactDr Nagendra Boopathy S

SRIHER

drsnboopathy@gmail.com7358560284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026